Skip to content

Privacy Policy

Privacy Policy

This privacy policy has been compiled to better serve those who are concerned with how their ‘Personally Identifiable Information’ (PII) is being used online. PII, as described in US privacy law and information security, is information that can be used on its own or with other information to identify, contact, or locate a single person, or to identify an individual in context. Please read our privacy policy carefully to get a clear understanding of how we collect, use, protect or otherwise handle your Personally Identifiable Information in accordance with our website.

 

What personal information do we collect from the people that visit our blog, website or app?

We do not collect information from visitors of our site.
or other details to help you with your experience.

 

When do we collect information?

We collect information from you when you fill out a form or enter information on our site.

 

Provide us with feedback on our products or services

How do we use your information?

We may use the information we collect from you when you register, make a purchase, sign up for our newsletter, respond to a survey or marketing communication, surf the website, or use certain other site features in the following ways:

  • To improve our website in order to better serve you.
  • To allow us to better service you in responding to your customer service requests.
  • To administer a contest, promotion, survey or other site feature.
  • To ask for ratings and reviews of services or products

 

How do we protect your information?

Our website is scanned on a regular basis for security holes and known vulnerabilities in order to make your visit to our site as safe as possible.

We do not use Malware Scanning.

We do not use an SSL certificate

  • We only provide articles and information. We never ask for personal or private information like names, email addresses, or credit card numbers.

 

Do we use ‘cookies’?

Yes. Cookies are small files that a site or its service provider transfers to your computer’s hard drive through your Web browser (if you allow) that enables the site’s or service provider’s systems to recognize your browser and capture and remember certain information. For instance, we use cookies to help us remember and process the items in your shopping cart. They are also used to help us understand your preferences based on previous or current site activity, which enables us to provide you with improved services. We also use cookies to help us compile aggregate data about site traffic and site interaction so that we can offer better site experiences and tools in the future.

 

We use cookies to:

  • Understand and save user’s preferences for future visits.
  • Keep track of advertisements.

You can choose to have your computer warn you each time a cookie is being sent, or you can choose to turn off all cookies. You do this through your browser settings. Since browser is a little different, look at your browser’s Help Menu to learn the correct way to modify your cookies.

If you turn cookies off, Some of the features that make your site experience more efficient may not function properly. It won’t affect the user’s experience that make your site experience more efficient and may not function properly.

 

Third-party disclosure

We do not sell, trade, or otherwise transfer to outside parties your Personally Identifiable Information.

 

Third-party links

We do not include or offer third-party products or services on our website.

 

Google

Google’s advertising requirements can be summed up by Google’s Advertising Principles. They are put in place to provide a positive experience for users. https://support.google.com/adwordspolicy/answer/1316548?hl=en

We have not enabled Google AdSense on our site but we may do so in the future.

 

COPPA (Children Online Privacy Protection Act)

When it comes to the collection of personal information from children under the age of 13 years old, the Children’s Online Privacy Protection Act (COPPA) puts parents in control. The Federal Trade Commission, United States’ consumer protection agency, enforces the COPPA Rule, which spells out what operators of websites and online services must do to protect children’s privacy and safety online.

We do not specifically market to children under the age of 13 years old.
Do we let third-parties, including ad networks or plug-ins collect PII from children under 13?

 

Fair Information Practices

The Fair Information Practices Principles form the backbone of privacy law in the United States and the concepts they include have played a significant role in the development of data protection laws around the globe. Understanding the Fair Information Practice Principles and how they should be implemented is critical to comply with the various privacy laws that protect personal information.

In order to be in line with Fair Information Practices we will take the following responsive action, should a data breach occur:
We will notify you via email

  • Within 7 business days

We also agree to the Individual Redress Principle which requires that individuals have the right to legally pursue enforceable rights against data collectors and processors who fail to adhere to the law. This principle requires not only that individuals have enforceable rights against data users, but also that individuals have recourse to courts or government agencies to investigate and/or prosecute non-compliance by data processors.

Jarmila Yu

Jarmila Yu is an award-winning globally ranked Top100 Chief Marketing Officer, she is a Chartered Marketer and Fellow of both the Institute of Data and Marketing and the Chartered Institute of Marketing. She has over 25 years of experience working with fast paced pioneering IT and professional services companies, ranging from start-ups to blue chips in B2B and B2C.

Jarmila is an entrepreneurial marketing strategist who has a passion for innovation, and a track record for growing and transforming business through efficient, effective, and impactful marketing. Her role as CMO for Momentum Pharma is to ensure the marketing and brand is fit-for-purpose, enabling the company to deliver on its mission to provide the highest calibre of excellence to support its clients in continuing to make medical breakthroughs that improves the quality of life and saves lives. 

Cindy Abbas

Cindy is Momentum Pharma’s Administration Manager and joined the company in May 2016 where she performs many roles for the firm.  These include corresponding with Sponsors and the Consultants on contractual administration, checking and organising the submission of monthly invoices and expenses of the Consultants.  Cindy is the principal controller for the Momentum Pharma Database.

Cindy started her career in 1989 and has a strong Accounting and Finance background. She has worked for Global Financial companies in a number of roles including; Team Leader in the Accounting Department and Account Manager for a large US based client.

Matthew Melton

Matthew is Momentum Pharma’s Chief Information Officer. He created the bespoke Database and other platforms that the firm uses. Matthew has an engineering and IT background with a broad technical base.

Matthew has worked in the medical device field during his time with a UK engineering company where he programmed the Hardware Control and UI Software design for the NT1000 radio-frequency generator for Thermal Lesioning medical equipment within an ISO 9001:1994 ‘Quality Systems Manufacturing Environment’. 

Matthew’s technical skills include electrical and electronic software engineering, systems design and administration.  He holds a MSc in Computing and a BEng in Electronic Engineering from Cardiff University of Wales. 

Kristina Valenkova

Joined Momentum Pharma in September 2022 as the Global Operations Coordinator. Kristina has a degree in Design and Innovation with a strong background in Information Technology.

Building upon her knowledge and experience, Kristina’s role is to facilitate continual development of Momentum’s operations around the world. Working alongside the CEO and COO to implement corporate strategy, assisting with the design, development and implementation of bespoke Momentum systems. Kristina also develops and maintains direct relationships with Momentum’s clients and consultants.

Ellesha Nicholas

Joined Momentum Pharma in February 2023 as the Operations Administrator. Ellesha’s role is focused on the administrative and operational day-to-day activities of Momentum Pharma.

Ellesha graduated from Harper Adams University with a BSc degree in Animal Behaviour and Welfare and has successfully achieved a Gold Duke of Edinburgh Award in 2015.

Jon Melton

Graduated from the University of East Anglia with a BA Honours degree in Business Studies and his professional career began in the Insurance and Reinsurance industry in April 2000.  

In 2013, Jon co-founded Momentum Pharma where he holds the role of Chief Operating Officer (COO).

Jon’s career in (Re)Insurance has been wide-ranging in terms of activity and territory. He supported clients and sourced business globally at each stage of his career within the 3 largest global broking houses (Willis, Marsh and Aon). 

Jon also has an in-depth experience in Leadership, Project Management and global business transactions.

Melissa Melton

CEO of Momentum Pharma, possesses over 20 years of clinical research and development experience.  During this time, she has worked extensively in the field throughout the US, Canada, UK and Europe (Finland, Sweden, Belgium, Spain, France, Italy and Ireland). 

Melissa is a Senior Clinical Trial Consultant which roles include; Clinical Program Manager, Senior CRA, ICH/GCP Quality Assurance Consultant, and CRO Oversight Lead.  She has worked for global pharmaceutical giants such as: Roche and J&J, as well as CROs and multiple progressive, cutting-edge Biotech firms. 

Her experience is deep in a myriad of therapeutic areas including: adult and paediatric oncology, haematology, cardiovascular, central nervous system, rare genetic disease and more.  Melissa has been instrumental in relationship building with key opinion leaders, increasing global program development and risk assessment. 

During her expansive career, she has worked on multiple FDA/EMA block buster drugs including the first in class anti-retro viral for HIV (Fuzeon) and numerous life changing Oncology drugs (Avastin, Herceptin, Xeloda and Imbruvica).  Melissa holds a BA in Psychology from the University of Arizona.  She understands the Sponsor’s needs implicitly, her speciality is strategic plans of action for global development.

Dr Helen Buck

Dr. Helen Buck is Momentum’s Consulting Quality and Risk Assessment Manager. She brings to the team 25 years of clinical trials industry expertise and has developed the company’s Standard Operating Procedures (SOP) library, as well as many study plan templates.

Helen has worked on many aspects of clinical trials since starting her Consulting career in 2003 including medical writing and conduct of clinical programmes to ICH GCP guidelines among other roles. Dr. Helen Buck has a PhD in Neuroscience.